- Home
- QSI vs CVRX Comparison
QSI vs CVRX Comparison
Compare QSI & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QSI | CVRX |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.6M | 139.8M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | QSI | CVRX |
|---|---|---|
| Price | $0.81 | $3.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $1.00 | ★ $10.50 |
| AVG Volume (30 Days) | ★ 3.2M | 1.5M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.17 | 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | $2,436,000.00 | ★ $56,651,000.00 |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | $618.07 | $17.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.45 |
| 52 Week Low | $0.69 | $2.20 |
| 52 Week High | $3.10 | $11.30 |
Technical Indicators
Market Signals| Indicator | QSI | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 52.92 | 42.52 |
| Support Level | $0.70 | $2.20 |
| Resistance Level | $1.06 | $6.06 |
| Average True Range (ATR) | 0.07 | 0.29 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 53.26 | 88.52 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.